Evaluating Vitamin D and LL-37 Levels in Peri-Implant Diseases
Background
Peri-implant diseases, including peri-implant mucositis and peri-implantitis, are inflammatory conditions affecting the soft and hard tissues surrounding dental implants, posing a significant challenge to long-term implant success. 25(OH)D3 (a form of vitamin D) and LL-37 (an antimicrobial peptide) are known to play roles in immune response and tissue healing. However, their specific levels in the peri-implant sulcus fluid of patients with these conditions remain poorly characterized, representing a critical knowledge gap.
Study Design
Results
As this study is currently NOT_YET_RECRUITING and scheduled to start in late 2025, no results are available yet. However, the researchers aim to determine if there are significant differences in the levels of 25(OH)D3 and LL-37 among the healthy, peri-implant mucositis, and peri-implantitis groups. They hypothesize that altered levels of these biomarkers will be associated with the presence and severity of peri-implant diseases, with peri-implant mucositis defined by PPD of 5.0 mm and peri-implantitis by bone loss over 5 mm. The primary objective is to quantify and compare 25(OH)D3 and LL-37 levels in peri-implant sulcus fluid across distinct peri-implant health statuses.
Why It Matters
Identifying specific biomarkers like 25(OH)D3 and LL-37 in peri-implant sulcus fluid could offer valuable insights into the pathogenesis of peri-implant diseases. If significant correlations are found, these markers could potentially serve as early diagnostic indicators or targets for therapeutic interventions. This research could pave the way for novel strategies to prevent and manage peri-implant complications, improving long-term dental implant success. Future steps would involve validating these findings in larger cohorts and exploring their utility in clinical practice, potentially leading to Phase II human trials.